| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 14/11/2012 | 12h16 | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 08/11/2012 | 18h10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 08/11/2012 | 18h10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 08/11/2012 | 17h57 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 08/11/2012 | 17h57 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 07/11/2012 | 23h29 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 07/11/2012 | 23h29 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 06/11/2012 | 23h27 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 06/11/2012 | 23h27 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 06/11/2012 | 21h03 | PR Newswire (US) | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Schiff Nutrition International, Inc. (SHF), OPNET Technol... | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 06/11/2012 | 17h12 | PR Newswire (US) | Rigrodsky & Long, P.A. Announces Investigations Of OPNET Technologies, Inc., Schiff Nutrition International, Inc. and MOD-PAC... | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 05/11/2012 | 23h15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 05/11/2012 | 16h38 | PR Newswire (US) | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Trunkbow International Holdings Limited (TBOW), OPNET Tec... | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 03/11/2012 | 00h00 | Business Wire | Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of OPNET Technologies Inc. (OPNT) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 23h30 | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of OPNET Technologies, Inc. | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 20h56 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 20h56 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 20h56 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 19h44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 19h44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 19h44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 19h44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 19h44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |
| 02/11/2012 | 11h04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPNT | Opiant Pharmaceuticals Inc |